Sens. Wyden and Alsobrooks are investigating whether RFK Jr. misled Congress about his 2019 Samoa trip. What the documents show and what HHS says.
Read More : RFK Jr. Senate Investigation: Senators Probe Kennedy’s Samoa Trip and Vaccine TestimonyPennsylvania’s measles outbreak tops 1,500 cases. How a Lancaster County midwife’s experience with pregnant patients is changing vaccine attitudes.
Read More : Pennsylvania Measles Outbreak 2026: Midwife’s Experience Changes Vaccine ViewsA second Oregon woman sues Kaiser Permanente for $23 million, alleging a podiatrist injected rubbing alcohol instead of anesthetic before toenail removal.
Read More : Second Woman Sues Kaiser Permanente Over Alleged Rubbing Alcohol InjectionA DBT pioneer’s legacy, Strategy’s MSCI index removal and Nvidia’s board investigation: three unrelated stories that share a lesson about trust and accountability.
Read More : Trust Under Pressure: Marsha Linehan’s DBT Legacy, Strategy’s MSCI Removal and Nvidia’s Governance TestAfter her MS misdiagnosis, Christina Applegate wonders if her breast implants could explain her symptoms. What she said, and what science says about BII.
Read More : Christina Applegate Questions Whether Breast Implants Are Behind Her Health Struggles After MS MisdiagnosisThe FDA now requires Ozempic, Wegovy and other GLP-1 drugs to warn about NAION, a rare eye condition linked to permanent vision loss. Here’s what changed.
Read More : FDA Orders New Warning Labels for Ozempic and Wegovy Over Rare Risk of Permanent Vision LossMore parents are declining the newborn vitamin K shot. Learn what vitamin K deficiency bleeding is, what new research shows and what to ask your pediatrician.
Read More : Why Newborn Vitamin K Shots Matter: Understanding the Risks of Refusing the InjectionThe FDA’s GLP-1 NAION warning now covers Ozempic, Wegovy, Mounjaro and Zepbound. What NAION is, the trial data, lawsuits, global rules and what to do.
Read More : FDA Issues GLP-1 NAION Warning: What Ozempic and Other Weight Loss Drug Users Should KnowThe FDA now requires GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound to warn about NAION, a rare eye condition. Here’s what it means for patients.
Read More : FDA Issues New Vision Loss Warning for GLP-1 Weight Loss Drugs: What Patients Need to KnowCold, flu, COVID-19 and RSV can look alike. Learn the key differences, how four-in-one home tests work, treatment options and when to seek care.
Read More : Cold, Flu, COVID-19 or RSV? How to Tell the Difference, Get Tested and Stay Safe This Season